Matthew Smith

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Autoimmune Experimental Encephalomyelitis 69%
3. Demyelinating Diseases 43%
4. Oligodendrocyte Precursor Cells 41%
5. Cuprizone 35%
6. Oligodendroglia 33%
7. Intermediate Filaments 28%
8. Remyelination 27%
9. Astrocytes 24%
10. Central Nervous System 22%
11. Myelin Sheath 20%
12. T-Lymphocytes 19%
13. Light 18%
14. Inflammation 17%
15. Brain 14%
16. Induced Pluripotent Stem Cells 14%
17. Sphingomyelin Phosphodiesterase 14%
18. Glucagon-Like Peptide-1 Receptor 13%
19. Optic Neuritis 13%
20. Serum 12%
21. Microglia 12%
22. T-Lymphocyte Subsets 12%
23. White Matter 12%
24. Retinal Ganglion Cells 12%
25. Metabolomics 11%
26. Autoimmunity 10%
27. Pathology 10%
28. ibudilast 9%
29. Mesenchymal Stem Cells 9%
30. bryostatin 1 8%
31. Therapeutics 8%
32. Metabolome 8%
33. Chronic Progressive Multiple Sclerosis 8%
34. Cell Differentiation 8%
35. Dimethyl Fumarate 8%
36. dectin 1 8%
37. Macrophage Colony-Stimulating Factor Receptors 7%
38. Gray Matter 7%
39. SARS Virus 7%
40. Hashimoto's encephalitis 7%
41. Atrophy 7%
42. Visual Pathways 7%
43. Aromatic Amino Acids 7%
44. Complement C3 7%
45. Macrophage Migration-Inhibitory Factors 7%
46. Th17 Cells 6%
47. Quetiapine Fumarate 6%
48. Meninges 6%
49. Neuroglia 6%
50. Macrophage Colony-Stimulating Factor 6%